Cointime

Zilia

company

About

Zilia is a medical device company that prevents, diagnose, and treats various ocular, neurological, and systemic conditions.

  • Quebec,Quebec,Canada
  • 11 - 50

Highlights

Total Funding Amount
$4M
Funding Rounds
2
Investors
3
Employee Profiles
2

Details

Last Funding Type
Seed
Last Funding Money Raised
$4M
Industries
Artificial Intelligence,Health Diagnostics,Medical Device
Founded date
Apr 1, 2012
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Zilia Inc.
Also Known As
Retnia

Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD. Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$4M
Zilia has raised a total of $4M in funding over 2 rounds. Their latest funding was raised on Aug 11, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 11, 2021 Seed $4M 2 Anges Quebec — Detail
Jun 25, 2019 Non-Equity Assistant — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Zilia is funded by 3 investors. Anges Quebec and Investissement Quebec are the most recent investors.
Investor Name Lead Investor Funding Round
Anges Quebec Yes Seed
Investissement Quebec — Seed
Creative Destruction Lab (CDL) — Non-Equity Assistant

Employee Profiles

Number of Employee Profiles
2
Zilia has 2 current employee profiles, including Executive Patrick Sauvageau
Patrick Sauvageau
Executive
Dominic Sauvageau
Executive
Cointime
Содержание
компания